Wasan Kumar

Stanford MD/MBA, Biotech

[Bob Kocher @bobkocher]

Here it is — our #HAScholar and @Health_Affairs summary of CMS’ latest value based care model, Making Care Primary: https://t.co/xxN0GE4Uch

Thanks to @eadashi and Wasan Kumar for their good work!

[Health Affairs @Health_Affairs]

In their new Forefront article, @kevin_schulman, @wasan_kumar, + @eadashi from @StanfordMed discuss how each generic entry drives down the cost of generic medications + how this pricing model helped to create strains in the generic drug market. https://t.co/aS40OqthNj

[Wasan Kumar @wasan_kumar]

Super excited to share this piece in @SSIReview with @JaroneLeeMD @ShuhanHeMD @PharmInnove! We look at missed opportunities for regulators to improve digital health in the US using lessons learned from virtual care delivery in the war in Ukraine.

[Stanford Social Innovation Review @SSIReview]

“Companies and regulators risk missing out on the biggest opportunities for raising productivity by requiring high-tech solutions.” @JaroneLeeMD @wasan_kumar Marianna Petrea-Imenokhoeva @PharmInnove @ShuhanHeMD share lessons from Ukrainian relief efforts. https://t.co/Acgc8ZmhLC

[Stanford Social Innovation Review @SSIReview]

“Companies and regulators risk missing out on the biggest opportunities for raising productivity by requiring high-tech solutions.” @JaroneLeeMD @wasan_kumar Marianna Petrea-Imenokhoeva @PharmInnove @ShuhanHeMD share lessons from Ukrainian relief efforts. https://t.co/Acgc8ZmhLC

[Wasan Kumar @wasan_kumar]

(8/8) As always, it was a delight to work with my mentor @kevin_schulman, and a big thanks to the editors @NEJM. If you have a minute, please check out the full article below: https://t.co/ZVkPprIpmr

[Wasan Kumar @wasan_kumar]

Today in @NEJM, @kevin_schulman and I discuss the 340B program, a drug discount program designed to help safety net hospitals that has since ballooned, with a recent Supreme Court case resulting in a potential multi-billion dollar federal settlement to hospitals (1/8)

[Wasan Kumar @wasan_kumar]

Given that the goals of advancing health equity are being smudged, how can we move forward with 340B? We suggest: Congressional action to restore lower payment rates and to require 340B profit ‘pass-through’ funding to address health disparities, among other policy actions (7/8)

[Wasan Kumar @wasan_kumar]

(7/7) Many thanks to my mentor and collaborator @eadashi, and to the editors @journalGIM. If you have a second, check out the full article below:
https://t.co/ZfbfrvkIkA

[Wasan Kumar @wasan_kumar]

Healthcare is expensive - But the costs of healthcare shouldn’t cause more harm than the benefits of care itself. @eadashi and I discuss the sweeping Biden Administration actions to curb medical debt and where we need to go from here in @journalgim (1/7)

[Wasan Kumar @wasan_kumar]

From a more humanistic standpoint, does it really make sense for us to use a debt-financed system for medical care? Something to consider.

[JGIM Journal of General Internal Medicine @JournalGIM]

@wasan_kumar and Eli Y Adashi discuss the recent Biden Administration actions to address medical debt and argue for stronger protections against predatory billing practices. https://t.co/ZDh1ILKD5O